Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003)

WM Clark*, A Davalos, LB Goldstein, M Kaste, L Leiter, J Zivin, H Sillesen, D Crimmins, S Davis, S Dimmitt, G Donnan, J Frayne, D Freilich, D Gillies, J Mikocki, C Schmidauer, R Schmidt, J De Bleecker, F Deceuninck, P Tack[No Value] Thijs, W Robberecht, JG Fernandes, M Beaudry, R Cote, K Hoyte, LH Lebrun, DJ Sahlas, J Norris, D Selchen, A Shuaib, D Simard, D Spence, P Teal, M Winger, G Matamala, A Jaramillo, R Cifkova, Z Kalita, [No Value] Rektor, H Rosolova, R Stipal, D Vaclavik, G Boysen, H Iversen, AR Anderson, JHA de Keyser, AM Boon, DJ Kamphuis, J Hollander, SPARCL Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)91-92
Number of pages2
JournalCerebrovascular Diseases
Volume17
Issue number1
Publication statusPublished - 2004

Cite this